In the laboratory of David Vaillancourt, Ph.D., researchers are applying a groundbreaking, noninvasive imaging biomarker they identified to discover better diagnostics and treatment of Parkinson’s disease.
In the Spring 2019 edition of Florida GATOR Magazine, a bond between Vaillancourt and Gary Keating — who was diagnosed with early-onset Parkinson’s 10 years ago — over basketball and finding a cure for Parkinson’s is highlighted.
“In Parkinson’s disease, your ability to perform the simplest of movements becomes problematic over time,” said Vaillancourt, a professor of applied physiology and kinesiology and member of the MBI Executive Committee. “So I’m very much attracted to alleviating that issue. I think that if we can do that, we’ll have a major impact on society and people’s wellbeing.”
